Prospeo
Hero Section BackgroundHero Section Background
Kadmon, a Sanofi Company

Kadmon, a Sanofi Company Email Formats

Biotechnology ResearchFlag of USManhattan, New York, United States21-50 Employees

Kadmon, a Sanofi Company Email Formats

Kadmon, a Sanofi Company uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@kadmon.com), used 66.7% of the time.

FormatExamplePercentage
{first name}.{last name}
john.doe@kadmon.com
66.7%
{first initial}.{last name}
j.doe@kadmon.com
33.3%

Key Contacts at Kadmon, a Sanofi Company

Flag of US

J.B. Wilcox

Senior Director Global Supply Chain

Flag of US

Tim Cowan

National Account Director

Flag of US

Bill Kerrish

Director Human Resources

Flag of US

Debbie Porter

Director, Pharmacovigilance/Medical Affairs

Flag of US

Matt Rumpler

Senior Director Of Operations

Flag of US

Megan Hann

Sr. Regional Director

Company overview

Headquarters450 East 29th Street, New York, NY 10016, US
Phone number+18339005366
Websites
NAICS541714
SIC873
Employees21-50
Socials

About Kadmon, a Sanofi Company

Kadmon, a Sanofi Company, is a biopharmaceutical company that discovers, develops and markets transformative therapies for unmet medical needs. Our team has a proven track record of successful drug development and commercialization. Our clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies. Our late-stage product candidate, belumosudil, is an orally administered selective inhibitor of Rho-associated coiled-coil kinase 2 (ROCK2) in development for the treatment of inflammatory and fibrotic diseases. A pivotal study of belumosudil is underway in chronic graft-versus-host disease (cGVHD), as well as a Phase 2 study in systemic sclerosis. Kadmon is also developing next-generation immuno-oncology therapies, specifically IL-15 containing fusion proteins, for the treatment of cancer. Our lead I-O product candidate, KD033, is an anti-PD-L1/IL-15 fusion protein in a Phase 1 clinical trial. Comments are no longer monitored.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry
Director
Senior

Employees by Department

Kadmon, a Sanofi Company has 12 employees across 7 departments.

Departments

Number of employees

Funding Data

Explore Kadmon, a Sanofi Company's funding history, including investment rounds, total capital raised, and key backers.

Funding Date
Round
Amount
Link to Article
2021-03-1116$240,000,000

Funding Insights

$240,000,000

Total funding amount

$240,000,000

Most recent funding amount

1

Number of funding rounds

Frequently asked questions

Kadmon, a Sanofi Company is located in Manhattan, New York, US.
You can reach Kadmon, a Sanofi Company at +18339005366.
Kadmon, a Sanofi Company has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.
Kadmon, a Sanofi Company has raised a total of $240,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles